CERS Q3 2023 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$40M+0.5% YoY

Gross Profit

$22M54.9% margin

Operating Income

-$5M-13.2% margin

Net Income

-$7M-18.3% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+2.4%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$13M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$206M

Total Liabilities

$157M

Stockholders' Equity

$48M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$40M	+0.5%
Gross Profit	$22M	$22M	-0.4%
Operating Income	-$5M	-$7M	+29.6%
Net Income	-$7M	-$8M	+14.3%

Revenue Segments

Product

$40M84%

Government Contract

$7M16%

Geographic Segments

North America

$26M65%

Europe Middle East And Africa

$14M34%

Other

$175,0000%